ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q4 2019. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,412,124 | +10.8% | 3,187,744 | +14.3% | 0.03% | +19.2% |
| Q2 2023 | $10,295,111 | +34.0% | 2,790,003 | +20.2% | 0.03% | +18.2% |
| Q1 2023 | $7,683,698 | -17.1% | 2,321,359 | -2.8% | 0.02% | -24.1% |
| Q4 2022 | $9,267,318 | +187.6% | 2,388,484 | +80.1% | 0.03% | +163.6% |
| Q3 2022 | $3,222,000 | +189.7% | 1,325,982 | +136.2% | 0.01% | +175.0% |
| Q2 2022 | $1,112,000 | +990.2% | 561,437 | +2105.8% | 0.00% | – |
| Q4 2019 | $102,000 | -51.4% | 25,453 | -53.2% | 0.00% | -100.0% |
| Q2 2019 | $210,000 | – | 54,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |